Alisar S. Zahr is the Director of Research and Clinical Development at Revision Skincare. She is responsible for conducting studies for new trial launches at Revision Skincare as well as following research and development of a product through its lifespan. Alisar received her PhD at Penn State in chemical engineering, specifically in designing drug delivery systems to treat cancer. This then led her to Harvard to complete a post doctorate program for Ophthalmology, where she published and patented technology in molecular biology.
Part Two: Alisar S. Zahr is the director of Research and Clinical Development at Revisions Skincare. In this episode we, learn about Revision's new product launch, the role Alisar played in bringing it to the market, and why it might make you look at sunflower seeds in a whole new light. Tune in to find out what type of product can make 100% of people in a clinical study see significant difference in their skin!